ProRelix Research is pleased to announce its participation in PharmaCore India 2026, a prominent platform bringing together key stakeholders from the pharmaceutical, biotechnology, and clinical research sectors. The event offers a valuable opportunity to engage with industry leaders, innovators, and decision-makers driving advancements in drug development and healthcare solutions.
As a trusted clinical research partner, ProRelix Research looks forward to meaningful discussions, potential collaborations, and contributing to the progress of efficient, compliant, and data-driven clinical research in India and beyond.
📍 Venue: Pavilion 1–3, Jio World Convention Centre, Mumbai
📅 Dates: 22nd to 24th April 2026
Join us at PharmaCore India 2026 to connect, collaborate, and contribute to the future of clinical research.
📩 Connect with us: [email protected]
🌐 Visit: www.prorelixresearch.com
Be the first to know the latest trends in clinical research, real-world case studies, and industry secrets.
ProRelix Research is the rapidly growing Contract/ Clinical Research Organization (CRO) with multi-country service capability supporting phase 1, 2, 3, & 4 clinical trials of Pharma, Biotech, Biopharma, Medical Device, Nutraceutical & Herbal companies to conduct in the USA, India, Europe & South East Asia.
